Neonatal supraventricular tachycardia: Outcomes over a 27-year period at a single institution

Acta Paediatrica, International Journal of Paediatrics

Volumn 97, Issue 8, 2008, Pages 1035-1039

  Gilljam, Thomas ^a,b   Jaeggi, Edgar ^a   Gow, Robert M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Infant; Neonatal; Prognosis; Supraventricular tachycardia

Indexed keywords

ADENOSINE; AMIODARONE; DIGOXIN; FLECAINIDE; PROCAINAMIDE; SOTALOL; VERAPAMIL; ANTIARRHYTHMIC AGENT;

ARTICLE; CARDIOVASCULAR RISK; CAREGIVER; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SUPRAVENTRICULAR TACHYCARDIA; ADOLESCENT; ADULT; CHILD; ELECTROCARDIOGRAPHY; FOLLOW UP; HEALTH STATUS; HEART RATE; INFANT; MASS SCREENING; PHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CHILD; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HEART RATE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MASS SCREENING; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 63849171390     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.00823.x     Document Type: Article

References (14)

1. Lemler MS, Schaffer MS. Neonatal supraventricular tachycardia: predictors of successful treatment withdrawal. Am Heart J 1997; 133: 130-1.
2. Deal B. Supraventricular tachycardia mechanisms and natural history. In: Deal B, Wolff G, Gelbrand H, editors. Current concepts in diagnosis of arrhythmias in infants and children, Futura Armonk, NY, 1998: 117-43.
3. Smith MB, Colford D, Human DH. Perinatal supraventricular tachycardia. Can J Cardiol 1992; 8: 565-8.
4. Weindling SN, Saul JP, Walsh EP. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 1996; 131: 66-72.
5. Tortoriello TA, Snyder CS, Smith EO, Fenrich AL, Friedman RA, Kertesz NJ. Frequency of recurrence among infants with supraventricular tachycardia and comparison of recurrence rates among those with and without preexcitation and among those with and without response to digoxin and/or propranolol therapy. Am J Cardiol 2003; 92: 1045-9.
6. Riggs TW, Byrd JA, Weinhouse E. Recurrence risk of supraventricular tachycardia in pediatric patients. Cardiology 1999; 91: 25-30.
7. Perry JC, Garson A. Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence. J Am Coll Cardiol 1990; 16: 1215-20.
8. Wolff GS, Han J, Curran J. Wolff-Parkinson-White syndrome in the neonate. Am J Cardiol 1978; 41: 559-63.
9. Woosley RL, Funck-Brentano C. Overview of the clinical pharmacology of antiarrhythmic drugs. Am J Cardiol 1988; 61: 61A-69A.
10. Sreeram N, Wren C. Supraventricular tachycardia in infants: response to initial treatment. Arch Dis Child 1990; 65: 127-9.
11. Bealer JF, Mantor PV, Wehling L, Tunell WP, Tuggle DW. Extracorporeal life support for nonimmune hydrops fetalis. J Pediatr Surg1997; 32: 1645-7.
12. Wong KK, Potts JE, Etheridge SP, Sanatani S. Medications used to manage supraventricular tachycardia in the infant. A North American survey. Pediatr Cardiol 2006; 27: 199-203.
13. Pfammatter JP, Bauersfeld U. Safety issues in the treatment of paediatric supraventricular tachycardias. Drug Saf 1998; 18: 345-56.
14. Wu MH, Chang YC, Lin JL, Young ML, Wang JK, Lue HC. Probability of supraventricular tachycardia recurrence in pediatric patients. Cardiology 1994; 85: 284-9.